Consilium MedicumConsilium MedicumConsilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum94505ArticlesСтатьиResearch ArticleProspects for treatment of rhinitis and rhinosinusitis: a review of the drug Euphorbium compositumПерспективы терапии ринитов и риносинуситов: обзор применения препарата Эуфорбиум композитумMarianovskiiA. AМарьяновскийАндрей Александрович

д-р мед. наук, проф. каф. госпитальной педиатрии №2 ГБОУ ВПО РНИМУ им. Н.И.Пирогова

Marjanovsky@arnebia.ruN.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian FederationГБОУ ВПО Российский национальный исследовательский медицинский университет им. Н.И.Пирогова Минздрава России15032016183VOL 18, NO3 (2016)ТОМ 18, №3 (2016)10410628122021Copyright ©; 2016, Consilium MedicumCopyright ©; 2016, ООО "Консилиум Медикум"2016Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc-sa/4.0https://consilium.orscience.ru/2075-1753/article/view/94505

The article presents a review of clinical studies on the efficacy and safety of an intranasal spray Euphorbium compositum. Spray for nasal application is an alternative to conventional drugs used for the treatment of rhinitis and sinusitis, which has no characteristic of these drugs side effects and limitations. The better tolerability compared with xylometazoline can recommend Euphorbium compositum as a means for long-term treatment of chronic sinusitis.The complex mechanism of action of the drug provides its antiviral and anti-inflammatory activity.

В статье представлен обзор клинических исследований эффективности и безопасности интраназального спрея Эуфорбиум композитум. Спрей для назального применения представляет собой альтернативу традиционным препаратам, используемым для лечения ринитов и синуситов, не имеющую характерных для этих препаратов побочных эффектов и ограничений. Лучшая переносимость по сравнению с ксилометазолином позволяет рекомендовать Эуфорбиум композитум в качестве средства для длительной терапии хронических синуситов. Комплексный механизм действия препарата обеспечивает его противовирусную и противовоспалительную активность.

rhinitissinusitisnatural ingredientssprayринитсинуситнатуральные компонентыспрейWeiser M, Clasen B.P.E. Randomized placebo controlled double - blind study of the clinical efficacy of the homeopathic Euphorbium compositum S-Nasal Spray in cases of chronic sinusitis. Forsch Komplementärmed Klass Naturheilkd 1994; 1: 251-9. English translation in: Biol Therapy 1995; 1: 4-11.Zenner S, Metelmann H. Therapeutic Experiences with a Homeopathic Nasal Spray. Hufeland Journal 1992;3:67-74.Gottwald R, Weiser M. Antihomotoxic treatment of chronic sinusitis: results of a drug monitoring study with Euphorbium compositum S Drops. Translated from Medicina Biológica 2000; 13 (3): 84-7.Sprenger F. A study with Euphorbium compositum nasal drops (metered dose spray without propellant gas). J General Practice 1984; 60 (27): 1164-8.Connert W.D, Maiwald J. Therapie chronisch - medikamentös und vasormotorisch bedingter rhinopathien. Erfahrungen mit einem biotherapeutischen nasenspray. Therapiewoche 1987; 37: 1179-86. English translation available in: Connert W.D, Maiwald J. The therapy of rhinopathy: results of application of a biotherapeutic nasal spray. Biol Therapy 1991; 9 (4): 182-92.Weiser M, Gottwald R. Homöopathische Nasentropfen lassen bei Kindern Rhinitis und Sinusitis schneller abklingen. Therapeutische Mitteilungen. Gesundes Leben 1999; 6: 63.Ammerschläger H, Klein P, Weiser M, Oberbaum M. Treatment of infl ammatory diseases of the upper respiratory tract - comparison of a homeopathic complex remedy with xylometazoline. Forsch Komplementärmed Klass Naturheilkd 2005; 12: 24-31.Urlea-Schön M.I. Effectiveness and tolerability of Euphorbium comp SN for the symptomatic treatment of rhinitis in children aged 2-6 years. Eur J Int Med 2009; 1: 236 (Abstract PO-023).Raab V. Practice report. Further therapeutic experience with Euphorbium compositum nasal drops (metered dose spray without propellant gas) in ENT practice. Biologische Medizin 1982; 4: 176-9.Glatthaar-Saalmüller B, Fallier-Becker P. Antiviral action of Euphorbium compositum and its components. Forsch Komplementärmed Klass Naturheilkd 2001; 4: 207-12.Glatthaar-Saalmüller B et al. Euphorbium compositum: viruses of the upper respiratory tract inhibited. Biologische Medizin 2002; 4: 194-5.Metelmann H, Glatthaar-Saalmüller B. Antiviral action of a homeopathic medication. Biomed Ther 2000; 18 (1): 160-4.Schmolz M, Metelmann H. Modulation of cytokine synthesis in human leukocytes by individual components of a combination homeopathic nasal spray. Biol Therapy 1999; 17 (2): 61-3; 75.Dykewicz M.S, Hamilos D.L. Rhinitis and sinusitis. J Allergy Clin Immunol 2010; 125 (2; Suppl. 2): S103-15.Fokkens W.J, Lund V.J, Mullol J et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. Rhinology 2012; 50 (Suppl. 23): 1-298.Wallace D.V, Dykewicz M.S, Bernstein D.I et al. Joint Task Force on Practice; American Academy of Allergy; Asthma & Immunology; American College of Allergy; Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008; 122 (2; Suppl): S1-84.Rosenfeld R.M, Andes D, Bhattacharyya N et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 2007; 137 (3; Suppl.): S1-31.Settipane R.A, Charnock D.R. Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy Immunol 2007; 19: 23-34.Hamilos D.L. Chronic rhinosinusitis patterns of illness. Clin Allergy Immunol 2007; 20: 1-13.Mattos J.L, Woodard C.R, Payne S.C. Trends in common rhinologic illnesses: analysis of U.S. healthcare surveys 1995-2007. Int Forum Allergy Rhinol 2011; 1 (1): 3-12.Punekar Y.S, Sheikh A. Establishing the incidence and prevalence of clinician - diagnosed allergic conditions in children and adolescents using routinely collected data from general practices. Clin Exp Allergy 2009; 39 (8): 1209-16.Ghouri N, Hippisley-Cox J, Newton J, Sheikh A. Trends in the epidemiology and prescribing of medication for allergic rhinitis in England. J R Soc Med 2008; 101 (9): 466-72.Klossek J.M, Annesi-Maesano I, Pribil C, Didier A. [INSTANT: national survey of allergic rhinitis in a French adult population based - sample]. Presse Med 2009; 38 (9): 1220-9.Quercia O, Incorvaia C, Puccinelli P et al. Prevalence of allergic disorders in Italy: the Cotignola population study. Eur Ann Allergy Clin Immunol 2012; 44 (1): 5-11.Bhattacharyya N. Functional limitations and workdays lost associated with chronic rhinosinusitis and allergic rhinitis. Am J Rhinol Allergy 2012; 26 (2): 120-2.Hastan D, Fokkens W.J, Bachert C et al. Chronic rhinosinusitis in Europe - an underestimated disease. A GA(2)LEN study. Allergy 2011; 66 (9): 1216-23.Jarvis D, Newson R, Lotvall J et al. Asthma in adults and its association with chronic rhinosinusitis: the GA(2)LEN survey in Europe. Allergy 2012; 67 (1): 91-8.Skoner D.P. Complications of allergic rhinitis. J Allergy Clin Immunol 2000; 105 (6; Pt 2): S605-609.Cruz A.A, Popov T, Pawankar R et al. ARIA Initiative Scientifi c Committee. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy 2007; 62 (Suppl. 84): 1-41.De Groot E.P, Nijkamp A, Duiverman E.J, Brand P.L. Allergic rhinitis is associated with poor asthma control in children with asthma. Thorax 2012; Jan 2. [Epub ahead of print]Dixon A.E. Rhinosinusitis and asthma: the missing link. Curr Opin Pulm Med 2009; 15 (1): 19-24.Lunn M, Craig T. Rhinitis and sleep. Sleep Med Rev 2011; 15 (5): 293-9.Meltzer E.O, Nathan R, Derebery J et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc 2009; 30 (3): 244-54.Craig T.J, Ferguson B.J, Krouse J.H. Sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis. Am J Otolaryngol 2008; 29 (3): 209-17.Hartgerink-Lutgens I, Vermeeren A, Vuurman E, Kremer B. Disturbed cognitive functions after nasal provocation in patients with seasonal allergic rhinitis. Clin Exp Allergy 2009; 39 (4): 500-8.Meltzer E.O, Gross G.N, Katial R, Storms W.W. Allergic rhinitis substantially impacts patient quality of life: fi ndings from the Nasal Allergy Survey Assessing Limitations. J Fam Pract 2012; 61 (2; Suppl.): S5-10.Nathan R.A. The burden of allergic rhinitis. Allergy Asthma Proc 2007; 28 (1): 3-9.Blaiss M.S. Pediatric allergic rhinitis: physical and mental complications. Allergy Asthma Proc 2008; 29 (1): 1-6.Vuurman E.F, van Veggel L.M, Uiterwijk M.M et al. Seasonal allergic rhinitis and antihistamine effects on children’s learning. Ann Allergy 1993; 71 (2): 121-6.Willsie S.K. Improved strategies and new treatment options for allergic rhinitis. J Am Osteopath Assoc 2002; 102 (6; Suppl. 2): S7-14.Puchelle E, Zahm J.M, Tournier J.M, Coraux C. Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3 (8): 726-33.